替莫西林对阴沟肠杆菌复合群的疗效及耐药突变出现
本研究评估替莫西林对阴沟肠杆菌复合群(ECC)的疗效。体外实验中,6株敏感菌中5株在2×MIC替莫西林暴露24小时后出现耐药突变。小鼠腹膜炎模型显示,E. asburiae感染时替莫西林组死亡率显著高于头孢吡肟组,且5/12小鼠出现耐药突变。结论提示替莫西林治疗严重ECC感染需谨慎。
要点
- 替莫西林对ECC敏感菌体外可快速诱导耐药突变
- E. asburiae感染小鼠中替莫西林疗效劣于头孢吡肟
- 严重ECC感染即使敏感也应慎用替莫西林
核心结论
- 替莫西林对ECC敏感菌体外可快速高频出现耐药突变,导致在高菌量腹膜炎模型中对E. asburiae感染无效。
研究设计与样本
- 体外研究联合小鼠腹膜炎高菌量模型,使用5株E. xiangfangensis尿路感染菌和一对E. asburiae临床分离株(TEM_S和TEM_R),以头孢吡肟为对照。
主要发现
- 6株TEM敏感菌中5株在体外暴露于2×MIC替莫西林24小时后出现耐药突变。
- E. asburiae感染小鼠中,替莫西林组死亡率显著高于头孢吡肟组,TEM_S感染小鼠中5/12出现耐药突变(头孢吡肟组0/12)。
- E. xiangfangensis感染小鼠中,替莫西林与头孢吡肟组无显著差异。
关键数值与推荐
- 体外耐药突变出现条件:2×MIC替莫西林暴露24小时。
- E. asburiae TEM_S感染小鼠中替莫西林组耐药突变出现5/12,头孢吡肟组0/12。
临床怎么用
- 治疗严重ECC感染时,即使菌株对替莫西林敏感,也应谨慎使用替莫西林。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Temocillin (TEM) is a seducing alternative to treat multidrug-resistant Enterobacterales thanks to a narrow spectrum, resistance to hydrolysis by ESBLs and some carbapenemases and limited impact on the gut microbiota. However, its efficacy on Enterobacter cloacae complex (ECC) is unclear. We evaluated TEM efficacy against ECC, in vitro and in a high-inoculum murine peritonitis model. METHODS: Five TEM-susceptible E. xiangfangensis UTI strains and an isogenic pair of E. asburiae clinical isolates-E. asburiae TEM_S and E. asburiae TEM_R-were studied. MICs, bactericidal kinetics and emergence of resistance were assessed in vitro and in a murine peritonitis model using cefepime (FEP) as reference. Both in vitro and in vivo resistant mutants were sequenced. RESULTS: Among the six TEM-S isolates tested, resistant mutants emerged in vitro in all but one after 24 h exposure to 2× MIC TEM. In vivo, when infected with E. asburiae (both TEM-S and TEM-R), mice mortality was significantly higher when treated with TEM compared with FEP, and resistant mutants emerged in 5/12 mice infected with E. asburiae TEM_S (0/12 with FEP). When infected with TEM_S E. xiangfangensis isolates, no significant difference was evidenced between mice treated with TEM or with FEP. CONCLUSIONS: Rapid and frequent emergence of resistant mutants to TEM was evidenced in vitro for distinct TEM-susceptible ECC strains. This led to TEM inefficacy in a high-inoculum peritonitis model with TEM_S E. asburiae. TEM should be used with caution for the treatment of severe ECC infections, even against susceptible strains.
引用
- Alanbari N, Amoura A, Guérin F, et al. Temocillin efficacy and emergence of resistance in Enterobacter cloacae Complex in a murine peritonitis model. J Antimicrob Chemother. 2026. PMID: 42141915. doi:10.1093/jac/dkag151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。